Oncotelic Therapeutics, Inc. (OTLC)

0.093 -0.01 (-6.06%) USD  |  OTCM  |  Dec 09, 15:39
More

Oncotelic Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for OTLC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade